drugset / Trial / NCT02443623
VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV
NaSingle-groupOpen-labelBasic science
Summary
Objectives: * To vaccinate plasma donors with the ACAM2000 smallpox vaccine thereby inducing an immune response resulting in high anti-vaccinia antibody titers. The collection of donor plasma will be used in the manufacturing of Vaccinia Immune Globulin Intravenous (VIGIV). * To ensure the safety of plasma donors vaccinated with ACAM2000 through the implementation of risk factor screening procedures and the collection of post-vaccination safety data.
Timeline
- Start
- 2015-09
- Primary completion
- 2021-07
- Completion
- 2021-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACAM2000 | Vaccine | — | — |